Restart Life Sciences Corp. (HEAL.CX)
0.07
0.00 (0.00%)
CAD |
CNSX |
Aug 25, 16:00
Restart Life Sciences Shareholders Equity (Quarterly) : 1.543M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.543M |
| December 31, 2025 | 1.287M |
| September 30, 2025 | -0.1483M |
| June 30, 2025 | 0.0627M |
| March 31, 2025 | 0.2661M |
| December 31, 2024 | -0.2991M |
| September 30, 2024 | -0.586M |
| June 30, 2024 | -1.046M |
| March 31, 2024 | -0.955M |
| December 31, 2023 | -0.8106M |
| September 30, 2023 | -0.601M |
| June 30, 2023 | -0.417M |
| March 31, 2023 | -0.1142M |
| December 31, 2022 | 0.0413M |
| September 30, 2022 | 0.9347M |
| June 30, 2022 | 1.199M |
| March 31, 2022 | 1.546M |
| December 31, 2021 | 0.4591M |
| September 30, 2021 | 2.732M |
| June 30, 2021 | 3.692M |
| March 31, 2021 | 4.110M |
| December 31, 2020 | 2.664M |
| September 30, 2020 | 6.886M |
| June 30, 2020 | 7.126M |
| March 31, 2020 | 6.076M |
| Date | Value |
|---|---|
| December 31, 2019 | 6.260M |
| September 30, 2019 | 6.510M |
| June 30, 2019 | 6.613M |
| March 31, 2019 | 6.992M |
| December 31, 2018 | 7.242M |
| September 30, 2018 | 7.381M |
| June 30, 2018 | 7.381M |
| March 31, 2018 | 7.506M |
| December 31, 2017 | 3.066M |
| September 30, 2017 | 0.7308M |
| June 30, 2017 | 0.8959M |
| March 31, 2017 | 0.8908M |
| December 31, 2016 | 0.6534M |
| September 30, 2016 | -0.0842M |
| June 30, 2016 | 0.1099M |
| March 31, 2016 | 0.1195M |
| December 31, 2015 | 0.1993M |
| September 30, 2015 | -0.0159M |
| June 30, 2015 | -0.0881M |
| March 31, 2015 | 0.0532M |
| December 31, 2014 | 0.1268M |
| September 30, 2014 | 1.742M |
| June 30, 2014 | 1.446M |
| March 31, 2014 | 1.445M |
| December 31, 2013 | 1.280M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Spectral Medical, Inc. | -70.07M |
| Resverlogix Corp. | -133.75M |
| Theratechnologies, Inc. | -38.39M |
| COSCIENS Biopharma, Inc. | 21.06M |
| Defence Therapeutics Inc | 5.415M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.284M |
| Total Liabilities (Quarterly) | 0.7405M |
| Debt to Equity Ratio | 0.2294 |
| Current Ratio | 2.006 |
| Net Debt Paydown Yield | -1.01% |